Heart Disease and Stroke in 2022: Research, Treatment, Prevention
THURSDAY, APRIL 21, 2022
6:00 – 7:00 PM ET | Zoom Webinar
Holly S. Andersen, M.D.
Attending Cardiologist, Associate Professor of Medicine
Director of Education & Outreach, The Ronald O. Perelman Heart Institute
NewYork-Presbyterian Hospital / Weill Cornell Medical Center
Trustee, The Rockefeller University
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University
Coronary heart disease and stroke are complex illnesses that emerge from a matrix of factors, including genes, diet, inflammation, stress, sleep, levels of physical activity, and many other aspects of human biology and behavior. On April 21, Holly S. Andersen, M.D., a distinguished cardiologist who serves as a Rockefeller University Trustee, will discuss the latest scientific and medical breakthroughs in cardiovascular health and their impact on disease prevention and patient care.
An authority on preventive cardiology and an advocate for heart disease awareness, Dr. Andersen is director of education and outreach for the Ronald O. Perelman Heart Institute at Weill Cornell Medicine. Her cardiology practice has focused on women’s heart health, the special concerns of athletes, and the management of mitral valve prolapse. As a physician attuned to the effects of healthcare disparities on disease risks and outcomes, Dr. Andersen has also been deeply involved in New York City’s battle against COVID-19. She will discuss the cardiovascular complications of COVID as well as efforts to limit damage to the circulatory system related to the disease.